Author:
Tasdemir Nilgun,Ding Kai,Savariau Laura,Levine Kevin M.,Du Tian,Elangovan Ashuvinee,Bossart Emily A.,Lee Adrian V.,Davidson Nancy E.,Oesterreich Steffi
Abstract
AbstractInvasive lobular carcinoma (ILC) is a histological subtype of breast cancer with distinct molecular and clinical features from the more common subtype invasive ductal carcinoma (IDC). ILC cells exhibit anchorage-independent growth in ultra-low attachment (ULA) suspension cultures, which is largely attributed to the loss of E-cadherin. In addition to anoikis resistance, herein we show that human ILC cell lines exhibit enhanced cell proliferation in ULA cultures as compared to IDC cells. Proteomic comparison of ILC and IDC cell lines identified induction of PI3K/Akt and p90-RSK pathways specifically in ULA culture in ILC cells. Further transcriptional profiling uncovered unique upregulation of the inhibitors of differentiation family transcription factors ID1 and ID3 in ILC ULA culture, the knockdown of which diminished the anchorage-independent growth of ILC cell lines through cell cycle arrest. We find that ID1 and ID3 expression is higher in human ILC tumors as compared to IDC, correlated with worse prognosis uniquely in patients with ILC and associated with upregulation of angiogenesis and matrisome-related genes. Altogether, our comprehensive study of anchorage independence in human ILC cell lines provides mechanistic insights and clinical implications for metastatic dissemination of ILC and implicates ID1 and ID3 as novel drivers and therapeutic targets for lobular breast cancer.
Funder
U.S. Department of Defense
National Institutes of Health
Tsinghua School of Medicine, China
Susan G. Komen
Breast Cancer Research Foundation
Metastatic Breast Cancer Network
Nicole Meloche Memorial Fund
Shear Family Foundation
Publisher
Springer Science and Business Media LLC
Reference68 articles.
1. Rakha, E. A. & Ellis, I. O. Lobular breast carcinoma and its variants. Semin. Diagn. Pathol. 27, 49–61 (2010).
2. McCart Reed, A. E., Kutasovic, J. R., Lakhani, S. R. & Simpson, P. T. Invasive lobular carcinoma of the breast: morphology, biomarkers and ’omics. Breast Cancer Res. 17, 12. https://doi.org/10.1186/s13058-015-0519-x (2015).
3. Rakha, E. A., Abd El Rehim, D., Pinder, S. E., Lewis, S. A. & Ellis, I. O. E-cadherin expression in invasive non-lobular carcinoma of the breast and its prognostic significance. Histopathology 46, 685–693. https://doi.org/10.1111/j.1365-2559.2005.02156.x (2005).
4. Berx, G. et al. E-cadherin is inactivated in a majority of invasive human lobular breast cancers by truncation mutations throughout its extracellular domain. Oncogene 13, 1919–1925 (1996).
5. Berx, G. & Van Roy, F. The E-cadherin/catenin complex: an important gatekeeper in breast cancer tumorigenesis and malignant progression. Breast Cancer Res. 3, 289–293 (2001).